Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Respiratory Care Units | 1 | 2020 | 111 | 0.19 | Why? |
| Semen | 2 | 2021 | 550 | 0.19 | Why? |
| Joint Diseases | 1 | 2017 | 122 | 0.16 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.15 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2017 | 309 | 0.14 | Why? |
| Cannula | 1 | 2020 | 750 | 0.14 | Why? |
| Interleukin-10 | 1 | 2021 | 1409 | 0.13 | Why? |
| Prosthesis-Related Infections | 1 | 2017 | 302 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Patient Transfer | 1 | 2020 | 898 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| HIV-1 | 2 | 2018 | 3365 | 0.12 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.10 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.10 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Italy | 4 | 2021 | 38444 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.07 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.06 | Why? |
| Semen Analysis | 1 | 2021 | 235 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2020 | 4260 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Oxazines | 1 | 2017 | 279 | 0.04 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 275 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Piperazines | 1 | 2017 | 445 | 0.03 | Why? |
| Male | 8 | 2021 | 367725 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Humans | 12 | 2021 | 930598 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2018 | 1517 | 0.03 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2017 | 363 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Pyridones | 1 | 2017 | 738 | 0.03 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.03 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.03 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |